News - Alteon Inc.
2008-01-18 09:00:59
Oxis International Inc. (OTCBB:OXIS) announced today that Synvista Therapeutics Inc intends to develop ALT-2074 for the treatment of psoriasis. ALT-2074 is one of Synvista's lead compounds under development for use in cardiovascular disease.
2007-07-24 15:15:31
MONTVALE, N.J., July 24 /PRNewswire-FirstCall/ -- Alteon Inc. announces that the reverse stock split of its common stock and name change will be in effect from Wednesday, July 25, 2007.
2007-07-18 09:19:13
MONTVALE, N.J., July 18 /PRNewswire-FirstCall/ -- Alteon Inc. announces that its Annual Meeting of Stockholders will be held on Friday, July 20, 2007 at 10:00 a.m. ET at the Park Ridge Marriott, 300 Brae Boulevard, Park Ridge, New Jersey.